(Q51330045)

3 April 2018

title

Circulating levels of perfluoroalkyl substances and prevalent diabetes in the elderly. (English)

1 reference

3 April 2018

2

Björn Zethelius

1 reference

3 April 2018

4

Bert van Bavel

1 reference

3 April 2018

1

Lars Lind

1 reference

3 April 2018

5

P Monica Lind

1 reference

3 April 2018

Samira Salihovic

series ordinal

3

object named as

Samira Salihovic

1 reference

3 April 2018

publication date

14 December 2013

1 reference

3 April 2018

published in

Diabetologia

1 reference

3 April 2018

volume

57

1 reference

3 April 2018

issue

3

1 reference

3 April 2018

page(s)

473-479

1 reference

3 April 2018

https://scigraph.springernature.com/pub.10.1007/s00125-013-3126-3

exact match

0 references

cites work

A first global production, emission, and environmental inventory for perfluorooctane sulfonate

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

The toxicology of perfluorooctanoate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Are PFCAs bioaccumulative? A critical review and comparison with regulatory criteria and persistent lipophilic compounds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Perfluoroalkyl acids: a review of monitoring and toxicological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Phthalate exposure associated with self-reported diabetes among Mexican women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Circulating levels of phthalate metabolites are associated with prevalent diabetes in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Urinary phthalate metabolite concentrations and diabetes among women in the National Health and Nutrition Examination Survey (NHANES) 2001-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Exposure to polyfluoroalkyl chemicals and cholesterol, body weight, and insulin resistance in the general U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Glucose and lipid homeostasis in adult rat is impaired by early-life exposure to perfluorooctane sulfonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

A cross-sectional analysis of type II diabetes in a community with exposure to perfluorooctanoic acid (PFOA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Association among serum perfluoroalkyl chemicals, glucose homeostasis, and metabolic syndrome in adolescents and adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Organochlorine exposure and incidence of diabetes in a cohort of Great Lakes sport fish consumers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Exposure to p,p'-DDE: a risk factor for type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Polychlorinated biphenyls and organochlorine pesticides in plasma predict development of type 2 diabetes in the elderly: the prospective investigation of the vasculature in Uppsala Seniors (PIVUS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

A comparison of three different methods to evaluate endothelium-dependent vasodilation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Reference values for 27 clinical chemistry tests in 70-year-old males and females

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

A rapid method for the determination of perfluoroalkyl substances including structural isomers of perfluorooctane sulfonic acid in human serum using 96-well plates and column-switching ultra-high performance liquid chromatography tandem mass spectro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Insulin resistance and its treatment by thiazolidinediones

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Effects of perfluoroalkyl compounds on mRNA expression levels of thyroid hormone-responsive genes in primary cultures of avian neuronal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Cross-sectional association between polyfluoroalkyl chemicals and cognitive limitation in the National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-3126-3

Pioglitazone added to conventional lipid-lowering treatment in familial combined hyperlipidaemia improves parameters of metabolic control: relation to liver, muscle and regional body fat content

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24337155

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00125-013-3126-3

1 reference

3 April 2018

PubMed ID

24337155

1 reference

3 April 2018